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ABSTRACT  
The need to reconcile effectiveness with shrinking budgets is pushing contemporary health services to 
develop co-production practices. But the patient is often an unwilling client and patient engagement with 
both their therapy and the relative organizational system remains largely unexplored. The article analyzes an 
Italian hospital’s co-production initiative and uses the results to reflect on what key factors impact the 
efficacy and the efficiency of healthcare co-production. The empirical evidence indicates that a) the socio-
organizational conditions of both the patients and the relevant actors must be taken into account to achieve 
the truly meaningful engagement of the patient, as opposed to merely symbolic acceptance in co-production 
practices, as opposed to just their symbolic acceptance; b) no divide exists between organizational 
production and client co-production, rather, it is a relationship of interdependence that in turn raises critical 
issues; and c) to take a significant step forward in our understanding of co-production and its managerial 
challenges we must perforce combine the use of public management studies and health psychology studies.  
 
Keywords: healthcare management, patient engagement, chronic illness, participatory research, 
organizational change 
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INTRODUCTION 
Coproduction occurs when governments partner with nongovernmental entities, including members of the 
public, to jointly produce services that governments previously produced on their own (Thomas, 2013). This 
issue is related to the public governance discourse that emphasises networks, partnerships and voluntary 
cooperation, moving beyond the polar models of State and market, public vs. business. 
The calls to make private contractors, non-profit organizations and volunteers the suppliers of services are 
underpinned by four key rationales or anticipated outcomes: advantages of scale, scope, supervision and 
learning (Entwistle, 2010, p. 162). Despite the often mixed evidence for these outcomes, the overall 
consensus is that individuals can be a reliable resource in many public sector areas and that each can 
contribute to the achievement of public purposes (Gash, Randall, & Sims, 2014; Thomas, 2013). 
Co-production has especially raised the interest of healthcare providers. In the developed countries the 
longer lifespan of an ageing population equates to a higher number of chronic diseases, increasing the need 
for long-term care facilities (Coyte, Laporte, Goodwin, & Organization, 2008) and, hence, more expensive 
healthcare services. This forces the public health providers to seek innovative organizational ways to manage 
the new needs that are emerging (Lega & Calciolari, 2012; OECD, 2011) 
The health systems have thus brought to light new rationales (Ewert & Evers, 2014, p. 430) even though the 
evidence that demonstrates a clear link between co-production and greater benefits for those involved is 
weak at best (Verschuere, Brandsen, & Pestoff, 2012, p. 1099). 
The extent to which co-production can be adopted and implemented depends on recognizing and dealing 
with a string of diverse factors. Up to now cost-savings, technical feasibility and strategies for encouraging 
the recalcitrant citizens to ‘get on board’ (Pollitt, 2012, p. 195) have dominated the debate. While 
recognizing the important light shed by the research programs that have investigated these issues, the paper 
argues that it is now time to move beyond the short-term perspective and the mono-disciplinary approach 
that has so far dominated the mainstream literature. 
The paper’s basic argument is that co-production, being the crossroad of several academic disciplines 
(Verschuere et al., 2012), must be addressed using a transversal approach that enables us to capture both 
the social and the organizational aspects. Unlike the buyer-seller relationship, co-production in the public 
sector implies a social exchange “in which the client ‘pays’ not with money but with behaviours” (Alford & 
O'Flynn, 2012, pp. 178, original emphasis). 
Consider, for example, the decisional processes that a healthcare organization (HCO) needs to embark on 
when it has to design and set up a home treatment plan for chronically ill patients. This kind of choice has a 
potential impact not only on the clinical, but also on the social, economic, organizational and other spheres, 
affecting all kinds of individuals and groups: from the clinicians and internal staff to the patients and 
caregivers. Orchestrating resources in a task environment subject to multiple strategic change initiatives 
(Kash, Spaulding, Johnson, & Gamm, 2014) and host to many actors poses significant challenges for the HCO 
administrators. Above all, the eliciting of the expected behaviours from those who “co-produce value for the 
public” (Alford & O'Flynn, 2012). But how should a public provider respond when the beneficiary (e.g., a 
chronically ill patient) is not fully committed, i.e., when they behave like an “unwilling client” (ibidem, p. 
177)? 
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The aim of the article is to guide senior managers in identifying the socio-organizational conditions that 
transform chronically ill patients from passive public-service recipients into engaged co-producers. 
Amalgamating the public management and the health psychology literatures and drawing on a qualitative 
case study conducted at a major Italian public hospital in collaboration with the patients, their association 
and the healthcare team, the article identifies what key factors influence the adoption and implementation 
of healthcare co-production initiatives. The paper focuses on a specific process known as Outpatient 
Parenteral Antimicrobial Therapy (‘OPAT’), which is the self-administration at home of intravenous antibiotic 
therapy by the patients themselves instead of undergoing the treatment with a circa 15-day stay in hospital, 
where it is usually carried out. 
Specifically, the paper posits the following questions:  
1. How do the organizational coordination and control processes change after the therapeutic practices 
traditionally requiring hospitalization cross the hospital’s boundaries to the outside?  
2. What approaches and work methods stimulate the active, ongoing participation of the relevant 
actors, i.e., what pushes them beyond the mere rite of participation? 
The first thing to emerge from the analysis is that failure to take account of the socio-organizational 
conditions of the patients and of the professional assumptions and values of the other relevant actors puts 
the entire engagement endeavour at risk, making it deceptively apparent and, hence, less efficacious. 
Second, there is no divide between organizational production and client co-production; rather, the activities 
(or activity segments) are redistributed among those who provide the care, i.e., the caregivers, and those 
who receive the care, i.e., the caretakers; which increases the managerial coordination and control effort. 
Third, the study shows that if we combine the use of public management studies and healthcare psychology 
studies we can take a significant step forward in our understanding of co-production and its managerial 
challenges. 
The article contributes to the health services co-production literature in two specific ways:  
• it underlines the conceptual convergence of engagement and co-production;  
• it demonstrates the potential advantages of a participated analysis of work practices, exploring the 
ambivalences that might arise when a practice is effectively incorporated in the work process 
(becoming a practice-in-use). 
And offers the following insights for practitioners: 
• give careful consideration to the decisions associated with home therapy; 
• expand the participative approach to include the pre-adoption phase of the co-production initiative; 
• carefully monitor the post-implementation costs of coordinating co-production practices. 
CO-PRODUCTION AND ENGAGEMENT 
Co-production is central to debates about public service provision in times of austerity not just because 
chronic diseases are a huge burden on healthcare expenditure (Rajan, Seidmann, & Dorsey, 2013), but above 
all because the bill for the services delivered by any kind of healthcare system is always paid by the 
consumer (through taxation, national insurance contributions, insurance premiums or privately). 
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Co-production refers to a fragmented set of activities, expectations, and rationales (Ewert & Evers, 2014, p. 
427). Unlike co-governance, which refers to organisations that help in the planning and design of public 
services, and co-management, which relates to the production of the service by a third sector organization in 
conjunction with the state (Brandsen & Pestoff, 2006), co-production is restricted to user involvement in the 
production of public services directly, with or without state intervention.  
The growing body of research that integrates the concept of co-production with policy, organizational and 
managerial concepts shows that scholars from diverse disciplines are beginning to embrace co-production as 
a useful conceptual framework for the study of public services (Schlappa & Imani, 2012).  
Scholars of business administration see extensive co-production as essential because customers must join in 
“customizing” many products and services (Thomas, 2013). In some cases ‘client co-production is a 
substitute for production by internal staff’ (Alford & O'Flynn, 2012, p. 178, emphasis in the original): ‘The 
issue for managers in these situation is whether the organization or the client will better perform the task. 
To inform these decisions, managers weigh up the relative cost-effectiveness of the two options, something 
akin to decisions about whether to contract public services out’ (Alford & O'Flynn, 2012). In other cases, co-
production is additive, i.e., it adds ‘user and/or community inputs to professional inputs or introduces 
professional support to previous individual self-help or community self-organizing’ (Brandsen & Pestoff, 
2006, p. 1123). 
Co-production has been the focus of several cost-effectiveness and benefit analyses. The main rationales or 
anticipated outcomes of co-production are reduced costs and better outcome (Alford & O'Flynn, 2012, p. 
179). For instance, a study of a training plan for 80,000 patients with long-term needs led Alford and O’Flynn 
to attribute the economic benefits to the reduced visits to GPs (7%), and fewer visits to Accident and 
Emergency (16%) reaping savings of between £27 and £58 per consultation avoided. Further, some patients 
reduced their hospital visits by half and reported significantly lower severity of symptoms following 
completion of the course. 
Collaborative co-production challenges the usual relationship between professionals and service users. It 
requires the latter to be considered experts in their own circumstances and therefore capable of making 
decisions and having control as responsible citizens (Boyle & Clarke Sand Burns, 2006). But co-production 
also implies a change in the role of the professionals from fixers of problems to facilitators who find 
solutions by working with their clients. This approach promotes the importance of front-line staff to the 
delivery of a service (Needham & Carr, 2009). 
There is general recognition that setting up co-productive relationships may have positive implications in 
health circumstances (Realpe & Wallace, 2010) and the term ‘engagement’ has now been widely adopted by 
the academic literature that studies the involvement of individual citizens and groups in co-production 
practices in healthcare settings. In particular, engagement in chronic care services can be defined as a 
process of commitment that in which the individual actively participates in managing their own healthcare 
program (Coulter, 2011, our emphasis; 2012). A concept that, as we can see, is very close to today’s idea of 
co-production even though it was incepted by different disciplinary parents (medicine and health 
psychology) and, indeed, ten years or so before its adoption in healthcare settings.  
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The term self-management was introduced by the medical literature in the 1960s to indicate the active 
participation and engagement of the patients and refers to the ability to carry out specific medical tasks 
autonomously (such as following a diet, using an inhaler, etc.). 
For many years the studies of the chronically ill patient-turned-own-caregiver interpreted engagement 
mainly as the sum of the whole of the abilities and behaviours needed to manage one’s own illness. For 
example, Gruman and colleagues (Gruman et al., 2010) have identified two settings of engaged patient 
actions, one related to the management of their conditions of illness (such as staying informed, monitoring 
certain health indicators, dealing with stress and the disease’s emotional consequences); the other related 
to the management of relations with the healthcare professionals (e.g., asking for explanations, 
communicating needs clearly, weighing up of treatment choices). In this sense, the strategies adopted to 
strengthen patient engagement aim to improve the person’s knowledge and skills through self-management 
training courses. The United States’ Chronic Disease Self-Management Program and the UK’s Expert Patients 
Programme are two examples of this approach. 
Despite the evidence of the positive results achieved by these interventions (Brady et al., 2013), there are 
limitations. First, this exclusively patient-centric approach is not enough to engage the most seriously ill 
patients who come from the lower socio-economic strata or have low levels of healthcare literacy 
(Greenhalgh, 2009; Wilson, Kendall, & Brooks, 2007), ignoring not only the equity criteria, but also the fact 
that the  desire and the ability of patients to engage with the healthcare professionals changes substantially, 
with behaviour that goes from full partnership to total deference. Second, the patient-centric approach 
seems unaware that many healthcare systems are not designed to foster engagement; indeed, some are 
even designed to actually discourage it. Fragmentation of services, restrictive policies and procedures can 
hinder patient and family involvement and can reduce access to personal health information (Edgman-
Levitan & Brady, 2013). Third, it disregards the potentially negative influence of the relational dynamics 
between healthcare staff and patients. For example, patients may initially be encouraged to ask the health 
professionals questions but are unlikely to repeat this behaviour if feedback is negative. Another matter is 
the mystic language that the professionals who fail to consult their patients for relevant inputs tend to use 
when writing educational materials, which leads the patients to dismiss them as useless or confusing instead 
of helpful.  
Other studies have since shifted the focus from the individual patient as the unit of analysis to the system of 
healthcare. As claimed in a recent report (Edgman-Levitan & Brady, 2013, p. 10) “engagement is a mutual 
relationship”: both the healthcare staff and the patient are co-responsible in building and managing 
programmes that maximize health. 
Seen from this angle, the focus of the clinical pathway switches from self-management to collaborative 
management. The patient is considered a full system partner, embracing the idea that the collaboration 
fostered between the patients, their families and the healthcare professionals is indispensable to effective 
engagement because it is precisely this collaboration that supports and strengthens the patient’s own 
responsibility and future self-management behaviours. Certain empirical evidence supports the advantages 
of switching to an engagement approach such as co-production as opposed to a one-sided intervention to 
change patient behaviour. Epping-Jordan et al (2004), for example, show that sporadic or short-term self-
management plans issued outside daily clinical practice failed to produce long-term benefits, although 
positive outcomes were recorded when such plans were integrated into routine clinical actions (Glasgow et 
al., 2002; Harris, Williams, Denni, Zwar, & Powel Davies, 2008; Norris, Lau, Smith, Schmid, & Engelgau, 2002). 
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A key factor in making patient self-management an integrated part of clinical practice is the design of clinical 
pathways that simultaneously increase the desire and skills of both the patients and their families and the 
healthcare professionals and management (Edgman-Levitan & Brady, 2013). Clearly there is no one best way 
to organize for co-production. What is certain, though, is that the challenges cross many levels and that 
these must all be addressed. 
A major challenge at the micro-level is to engage the patient in the co-production process in a cost-effective 
way, defining engagement as an ongoing process in which the patient (along with their family and the 
various caregivers) actively participates in their healthcare plan (Coulter, Parsons, & Askham, 2008). 
Engagement is crucial in cases of lifelong chronic illness but cannot be taken for granted, given that the 
patients “compelled to ‘receive’ the service provided” often show limited commitment, indeed, are unwilling 
clients (Alford & O'Flynn, 2012, p. 177; Bovaird & Loeffler, 2012; Thompson, 2007). At the meso-level, the 
challenge is to manage the interdependency between organizational production and client co-production 
(Alford & O'Flynn, 2012, p. 182) to ensure the patient engages with both their therapy and the responsible 
organizational system. This intermediate level is where the expert patient organization can play a decisive 
role as the interface between the individual patients and the healthcare system so that the former can ‘get 
what they are entitled to but also make the best possible choices’ (Ewert & Evers, 2014, p. 428). Finally, at 
the macro-level, a significant challenge for management practice is to align the autonomous choices with the 
healthcare offer and to manage the available resources in line with the broad policy objectives established 
for the adjacent sectors (e.g., social services) and other government levels.  
THE CASE STUDY 
In Italy, Intravenous Antibiotic Therapy (IAT) is generally administered to adult sufferers of cystic fibrosis as 
hospital inpatients. The case study analyzed in the paper is a co-production initiative that aims to enable the 
patient to undergo their IAT at home instead of in the hospital.  
The need to reduce hospital admissions on the client side and the increasing scarcity of hospital beds on the 
organizational side are the two drivers of the co-production initiative launched by the hospital’s Centro di 
Bioetica (Bioethics Centre), which calls for the clinical staff, the patients and the hospital’s healthcare 
management to design a home therapy pathway according to a joint decision-making logic that involves all 
the relevant actors and that promotes organizational simplification. 
According to the typology of Bovaird (2007), the participative methodology used in the design phase (see 
“Method”) denotes the co-production case study as an example of “user-community sole delivery of 
coplanned or co-designed services”, i.e., the patients, represented by the expert patients association, 
working alongside the healthcare professionals are fully involved in most aspects of the service design and 
planning of the service, which is then self-administered by the eligible patient. In fact, the patients are 
engaged in a two-phase action of co-production: the first phase of action is the design which calls for the 
patients of the Cystic Fibrosis Expert Patient Association to co-produce the informative training course that 
precedes the second action of co-production implementation, i.e., when the inpatient makes the switch 
from hospital-administered therapy to self-managed home therapy.  
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THE ORGANIZATIONAL CONTEXT 
The Cystic Fibrosis Centre (CFC) is located in the Pulmonary Ward of one hospital. The research was 
conducted in 2009 when the CFC was attended by 180 adult (18 years and older) patients. The CFC had one 
day-hospital bed (open weekdays), two consulting beds and six inpatient beds. The emergency telephone 
service is staffed 24/7 by the shift doctors. The CFC team consists of two physicians, one day nurse, two 
physiotherapists, one dietician and one social worker.  
CO-PRODUCTION WORK PRACTICE 
Cystic fibrosis (CF) is an inherited disease that affects different organs caused by a frameshift mutation in the 
gene for the protein cystic fibrosis transmembrane conductance regulator (CFTR), which is required to 
regulate the components of sweat, digestive fluids, and mucus. In particular, the build-up of thick, sticky 
mucus in the lungs, which is hard to expel via coughing, blocks the airways and makes it easy for bacteria to 
grow. This leads to repeated, serious lung infections and, over time, severe lung damage.   
No etiological treatment has yet been found for cystic fibrosis, which means that any deterioration in the CF 
patient’s pulmonary or infective condition is treated with a course of antibiotics. In the case of a serious 
worsening, the failure of the oral therapy or the body’s resistance to the oral antibiotics, the patient is 
prescribed intensive Intravenous Antibiotic Therapy that must be administered, on average, over a 15-day 
period. 
Outpatient Parenteral Antibiotic Therapy (OPAT) was introduced in the United States in the early 1970s for 
patients who require parenteral therapy but are well enough not to require hospitalization. Regarded as a 
standard of care in North America, where the main driver has been financial, the UK has only recently seen a 
considerable expansion of services (Chapman et al., 2009) and now considers it a highly clinically efficient, 
cost-effective and safe alternative to inpatient care where parenteral therapy is deemed necessary ( 
Chapman, 2013). 
In Italy, OPAT is far from widespread, especially in paediatric healthcare. In fact, the current standard for 
treating adult CF patients in Italy calls for the hospital to give them an approximately 15-day course of 
intravenous antibiotics as inpatients. Hospitalization is considered a better clinical approach because it 
allows the healthcare professionals to continually monitor, repair and maintain vein access, to evaluate the 
treatment’s efficacy, to plan diagnostic tests to help frame the patient’s clinical condition, to optimize the 
respiratory physiotherapy programme essential to clinical success, to keep complications in check and 
monitor any side effects, and to counter possible adverse reactions.   
At the time the research was conducted (2009), the CFC data showed that more than 50% of the patients 
receiving CFC treatment needed at least one course of IAT per year. Of these, around 1 in 5 administers at 
least one course at home. 
The CFC’s OPAT process – reconstructed through HFMEA (see ‘Method’) – usually commences when the 
patient asks to complete their antibiotic treatment at home. The healthcare team assesses the patient’s 
request to ensure that their clinical conditions are appropriate (mainly clinical conditions of average 
seriousness, absence of adverse reactions to the antibiotics). In addition, the physician and the social worker 
assess the adequacy and conditions of hygiene at the patient’s home and that this latter has one or more 
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caregivers to ensure continuous 24-hour monitoring over the entire period. Patients that meet these criteria 
then undergo a self-management therapy training course that enables them to take over from the nurses. 
Once the patient has proved capable of self-managing the OPAT and the drugs needed for the treatment have 
been sourced, the patient is discharged from hospital. It takes roughly 4-5 days to verify that the patient 
meets the criteria and to give them the relevant training, during which the patient stays in hospital and 
receives the first courses of OPAT.  
METHOD 
The study was carried out from the end of 2008 to 2010 and had the aim of evaluating and redesigning the 
clinical pathway of this chronic illness in order to actively involve the patients in the self-management of a 
specific therapy (Intravenous Antibiotic Therapy or ‘IAT’).  
The research adopted the co-operative inquiry approach (Heron & Reason, 2001) that identifies the group of 
different stakeholders as the main vehicle of knowledge advancement and change agent. The hospital’s 
Bioethics Centre decided to form a research group made up of CFC healthcare professionals (physicians, 
nurses, psychologist, social worker), representatives of the local Expert Patient Association (the chairman 
with, on rotation, another four patients) and two academic researchers (the second and third co-authors of 
this article). The hospital’s healthcare management formally adhered to the research group but did not 
attend the meetings. Figure 1, below, outlines the research path. 
Fig. 1. Research Path  
 
The research group was tasked with analyzing the work practices, exchanging experiences and observations, 
generating knowledge and deciding/verifying the actions needed to implement IAT. Work practices were 
analyzed through a revised version of proactive analysis (HFMEA, Health Care Failure Modes and Effects 
Analysis; (DeRosier, Stalhandske, Bagian, & Nudell, 2002) and the Analysis of Decision Nodes of the clinical 
pathway, applied in the context of focus groups of mixed composition (physicians, nurses, psychologist, 
social worker, expert patients, and two researchers of the hospital’s Bioethics unit).  
The HFMEA, reflecting the standard issued by the Joint Commission in 2001, enables the reconstruction of 
the flow of actions implemented during a therapy practice from the time of first contact through 
completion; identification of the potential weaknesses; measurement of the risks of error; and the sharing of 
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priority objectives of intervention to improve patient safety. The method’s principle output is worksheets, 
i.e., the graphic illustration of the action flow. The psychosocial analysis of the decisional nodes started with 
the reconstruction of the different ways to administer the IAT process (in hospital or at home). The analysis 
of the flow and its product (graphic illustration), in fact, produced a description of the outcomes of the 
decisional steps in dichotomous terms (yes/no), although the decisional process remained pretty much a 
black box. 
The analysis of the decisional nodes focus group mainly oriented the discussion to the expectations, 
emotions and thoughts inherent in the decisions related to managing the therapy; the tacit assumptions that 
motivated the exchanges and the distribution of the power between the actors; and the sharing of the 
spaces accorded to and by the patients. The aim of focusing on the decisional processes was to understand 
how each component interpreted the role of the patients in actively managing IAT, both in hospital and at 
home. The participants were asked to indicate what key issues required a decision and what were the most 
emotionally challenging and demanding. Each decision was then investigated to understand: i) the 
representations of the problem that they believed required a decision; ii) what options each actor had in 
mind to choose from; iii) who was given the decisional power; and iv) the doubts, difficulties and hurdles, if 
any, encountered in reaching that decision. Figure 2, below, shows an example of decision as represented in 
the flow chart (top half of Figure 2) and the areas investigated to open the black box of the decision. 
Fig. 2. Psychosocial analysis of decisional steps: Example 
 
The focus group discussions were recorded and then transcribed; the transcriptions were read and analyzed 
thematically in their entirety by two independent researchers (Duggleby, 2005). The reports ensuing from 
each phase of the clinical practice identify the questions perceived as characterizing, the actors involved in 
the problem, their representations of the problem and any divergences, and how the decision was reached. 
The reports and data produced by the analysis were shared with the members of the focus group to test the 
data’s reliability and the suggested interpretations. 
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FINDINGS 
Two main issues impact our analysis. First, the relevant actors usually have conflicting motives or goals. At 
least three main groups - the healthcare staff, the hospital administrators and, naturally, the patients – need 
to agree to and support the home care arrangements for conditions that traditionally require hospitalization. 
But these stakeholders have different interests, are not internally cohesive and have differing priorities and 
values, all of which hamper the process of obtaining the necessary support. Equally important, these groups 
have considerable power and could use it to block or undermine initiatives they dislike, a factor that should 
not be underestimated. Second, regardless of any divergence of goals, there is the knotty problem of 
coordinating the different options available. The people involved must choose a plan of action that is 
mutually compatible to arrive at an acceptable solution. 
The findings of the study can be grouped thematically: 
1. Organization change; 
2. Process representations; and  
3. Implementation. 
ORGANIZATION CHANGE  
Clinical reasons underpin the organizational decision to temporarily hospitalize IAT patients. In fact, the 
healthcare operators can better control and directly monitor the treatment and its outcomes when the 
patient is in hospital. However, OPAT introduces a new technology to the care processes of the CFC patients 
as an alternative to this general rule.  
In a nutshell, the transfer to home therapy implicates: a) disintegrating and fragmenting the various 
‘vertically integrated’ tasks (clinical, care, administrative) of IAT; b) changing the process interdependencies 
in line with the redistribution of activities among the various stakeholders in and outside the hospital; and c) 
bringing new actors from different institutional levels into the processes while ensuring continuity of care.  
The main steps taken by CFC to launch and monitor home intravenous therapy are: 
1. co-assess with the patient that their home is a safe environment in which to self-manage the 
intravenous antibiotic therapy; 
2. inform and train the patient during the patient’s hospital stay in how to manage the processes 
throughout the entire home care period; 
3. submit the therapy plan to the competent ASL (Italy’s national health service authority) to obtain the 
necessary drugs and supplies, duly documented in the patient’s medical file; 
4. activate the ADI (home care service) in those ASL equipped to provide the service; 
5. discharge the patient after the required drugs and supplies have been consigned; 
6. fix the date for the haematological tests and blood chemistries, clinical and physiotherapy check-ups 
during the intensive intravenous antibiotic therapy; 
7. fix the date for the check-up at the CFC Day Hospital; 
8. assess whether the patient needs to be newly admitted to hospital if their condition shows no 
improvement at the end of the home therapy. 
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This enables the logics that inform the ‘traditional’ IAT process and the ‘new’ OPAT process to live side by 
side. Patient clinical conditions guide CFC physicians in their decisions of selection, combination and order of 
application of the technologies. Nevertheless, it is clear that the effect of OPAT increases both the 
complexity and the uncertainty of the organizational environment.  
PROCESS REPRESENTATIONS 
The cooperative inquiry approach (Heron & Reason, 2001) underscores that giving the relevant actors 
decisional responsibility is a key driver of change in work practices. Therefore, the building of a clinical 
practice must be oriented to the collaborative management of the care with the two relating partners 
(patient with family on one side and healthcare professionals on the other) sharing the same representation 
of how things stand, of the ultimate goal, of what can be done and of what decisions to make on actions of 
change that are sustainable for all the parties involved. 
The authors used the Analysis of Decision Nodes focus group method to identify the different representations 
and to understand how each actor interpreted the active role of the patients in managing OPAT. 
From the patient’s perspective, the analysis showed that the decision to ask the doctors to prescribe OPAT 
came after the patient had made a solitary journey of inner reflection (or, at most, after discussing the option 
with their family). It seems that patients draw on a strong sense of self-selection to feel capable and “serene” 
before making their request:   
“I asked myself a bunch of questions before I made the request ... I know that 
being shut up in hospital ensures better treatment… so, for sure, I wasn’t about to 
submit my request until I really felt up to managing it at home.” (CFC patient)  
Home therapy causes the patient to form a representation in which desire mixes with fear to result in 
ambivalence. On one side, the less intrusive home therapy, and thus the lower impact of the disease itself on 
the patient’s personal and professional life, promotes a better quality of life. On the other, there is the fear 
of not being capable of successfully managing the home therapy, of not knowing who to call in the non-rare 
event that the PVC (peripheral venous catheter) slips out of the vein, and of wondering whether the therapy 
is less efficacious without the level of physiotherapy received in hospital. It emerged that the patients 
perceived OPAT as less of an opportunity or even a right and more of a “privilege” awarded by the doctors 
based on clinical criteria that were fairly obscure, even to the most informed and aware patients. 
The doctors’ decision not to advise the patients of the requisites needed to access the home therapy was a 
choice based on their fear of further antagonizing the many patients who do not meet those parameters. In 
fact, it is the risk dimension that prevails in the representation of the physicians:  
“Even after they’ve had tens of courses of the same drug, the therapy is still a 
potential source of risk [adverse reactions] but we still let them manage it at 
home”. (CFC physician) 
The doctors see several risks, and on both sides. The patient is at risk because they may not be able to deal 
with the albeit rare possibility of an adverse reaction if they are at home; they may have PVC problems and 
be unable to get immediate help from either their GP or the home nurse; and, out of sight of the physicians, 
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they may decide to reduce the doses and duration of the therapy. The risk for the physician is related to self 
and the professional responsibility of the prescribing doctor when no procedure has been agreed with the 
hospital’s administrators to legitimize the patient’s home therapy. 
Hence, OPAT is clearly perceived by the doctors as mainly a ‘concession’ to the requests of a few, select and 
reliable patients, while evaluating the home therapy option as an opportunity to free up hospital beds and 
put these and the department’s resources to more efficient use is relegated to the back burner. 
Moreover we noticed a divergence in representation based on the mapping of the patient eligibility 
assessment boundaries. According to the doctors, the final approval for OPAT must perforce include the 
suitability opinion of the nurse responsible for training the patient and the social worker’s assessment of the 
patient’s living conditions. However, the nurses, the social worker and the patients had no idea that the 
doctors considered such information an integral part of the final decision on eligibility and to authorize 
continuance of the treatment at home.  
The contribution of the different actors involved in the clinical practice to the focus group discussions 
revealed the different OPAT representations that were then shared with the others, but also highlighted the 
hard core issue, which was the danger/risk inherent in the home therapy method. 
This latter knowledge factor gave the group direction, enabling it to focus on solutions that made OPAT a 
sustainable practice that found favour with all the relevant actors.  
IMPLEMENTATION 
Going back over the research phases, we can see that those designated ‘Look’ and ‘Think’ were central to 
finding a common starting point for the planning phase that began in late 2009 and preceded the definition 
in 2010 of the implementation phase. 
The point of departure was, in fact, the realization of the need to develop a risk management strategy for 
OPAT. This set the research group to work on producing a series of organizationally sustainable artefacts 
that covered the needs of all the stakeholders. 
Above all, under the supervision of the hospital’s bioethics centre, the doctors and patients co-designed an 
‘informed consent form’ that covered both the patient’s need to be fully informed of the risks in plain, 
simple language and the physicians’ need to place certain limits on the extent of their responsibility in the 
event of patient harm. The informed consent form is the only document produced by the research group 
recognized by the hospital’s quality system. 
In addition, the doctors and patients co-designed a patient information sheet that set out clearly the clinical 
criteria used by the healthcare professionals to assess the patient’s eligibility for OPAT. This document was 
not only highly desired by the patients, but also gave the doctors a way to reduce potential conflicts and 
better deal with the non-eligible patients. 
Under the doctors’ supervision, the nurses and patients then co-designed two further documents: a nurse’s 
vade mecum defining the therapy training plan; and the patient’s therapy training check list. This latter 
describes the sequence of actions for correctly administering the therapy (preparation of the materials and 
work spaces, dilution of the pharmaceuticals, etc.) and identifies the phases in which the patient becomes 
14 
 
progressively autonomous over the arc of 4-5 days. These artefacts are the formalization of the training 
process that up till then had not been shared explicitly between the nurses and that the patient had had to 
memorize with the help of spontaneous note-taking. 
The final step was for the two doctors in charge of CFC to define the OPAT procedure in all its clinical, 
nursing and training components. Despite the fact that this document is fundamental to the recognition of a 
CFC clinical practice, however, the hospital has yet to incorporate it into the quality system. 
This latter consideration captures a primary need area that has failed to generate a response and that 
concerns the doctors’ request that the hospital administrators formally legitimize OPAT and indemnify them 
from the potential risk of patient harm. At the time of this writing, the informed consent form was the only 
formalization of OPAT recognized by hospital management. 
The monitoring of the home therapy by healthcare professionals and the provision of support in the event of 
PVC problems is the other highly salient risk domain identified by both doctors and patients alike. This 
domain calls into play the relationship with the local health services (home care nursing service and GP). The 
CFC had already prepared specific documentation to provide the GPs and the local health services with 
information on the therapy underway and the specific conditions of cystic fibrosis patients. Nevertheless, it 
was still necessary to formalize the as-yet missing and much-desired agreement between the hospital and 
the local health services needed to develop a generally accepted ‘continuity of assistance’ protocol for OPAT 
patients. Given the lack of response from hospital top management, CFC took it on itself to ask its social 
worker during the implementation phase to send a formal communication for each patient to ASL at the 
start of OPAT in order to obtain a written document that sanctioned the report submitted. 
DISCUSSION  
The response to the first research question “How do the organizational coordination and control processes 
change after the therapeutic practices traditionally requiring hospitalization cross the hospital’s boundaries 
to the outside?” needs to take account of two significant aspects: number one, the central role of the 
engaged patient and, number two, the role of the artefacts. 
The case study has shown how replacing hospital therapy with OPAT is a co-production choice that deeply 
involves the patients and their community: the family becomes a ‘care partner’ (Edgren, 1998). The highly 
intense relational context is a direct consequence of the particular conditions of the patients in question. 
The analysis confirms that no divide exists between HCO production and client co-production; indeed, OPAT 
redefines at least two levels of critical interdependencies: 
- the first, most obvious level is the content of the interdependencies, i.e., the ways in which the new 
activities must be integrated with the current organizational practices. The case study shows that CFC 
is the one that manages and controls (albeit partially) the connections between the different 
processes; 
- the second is the way in which interdependency is conceived. The growth in the number of actors and 
processes inherent in co-production practices increases the coordination input factor. Hence, the 
question moves to solutions and tools that enable complexity to be addressed as a permanent 
condition for the caregiver organization. If we accept this logic, then the management responsible for 
the external service has to ensure a minimum level of control between systems that continue to work 
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according to substantially heterogeneous methods (what CFC does today). On the other hand, a 
complete and systematic management would require a far greater organizational design effort that 
must necessarily involve top management.  
In general terms, to manage interdependencies, the organizations establish routines or rules, schedules and 
mechanisms of communication. The choice of which of these tools to adopt is dictated by the degree of 
stability and repetitiveness of the respective situations. However, it is essential that the organizations 
minimize coordination costs. In the case in question, the research group produced several artefacts but no 
protocol to ensure inclusion of the local health services’ relationship of responsibility. Further, the fact that 
the same documents have not been incorporated into CFC’s quality system means that not only does the 
research group’s work remain invisible, but also prevents the solution from becoming a good practice 
exportable to other care settings that routinely use OPAT; what we can call a missed organizational learning 
opportunity. In fact, the big hospitals are increasingly putting together multidisciplinary teams that specialize 
in the training and supervision of patients that need OPAT to treat diverse acute and chronic diseases. For 
example, Chapman et al. (2009) cite the case of the Sheffield OPAT service, established in 2005, which treats 
over 300 patients per year, saving over 3000 bed days annually. Moreover, the cost of OPAT amounts to 41% 
of equivalent inpatient costs for an Infectious Diseases Unit, 47% of equivalent inpatient costs using British 
national average costs and 61% of inpatient costs using minimum inpatient costs for each diagnosis. 
The study, with its focus on the change in organization and actor relations, confirms that the hospital service 
responsible for the chronically ill patient suffers no loss of control over the therapeutic practices; rather, the 
ability to control is transformed into something more complex. Completing at home a course of intravenous 
antibiotic treatment that started at CFC generates both advantages and disadvantages compared with 
finishing the course of treatment as a hospital inpatient. The advantages are not evenly distributed however, 
and it is the patient that benefits the most.  
As to the second research question “What approaches and work methods stimulate the active, ongoing 
participation of the relevant actors, i.e., what pushes them beyond the mere rite of participation? the 
response loops back to what we just said on the design of the artefacts. 
The case analyzed here had the goal of the sustainable implementation of OPAT and involved the research 
group in an intense work of co-design. This effort was underpinned by the precise methodology described 
earlier. All the actors involved in the research group co-produced a number of tools in an effective and 
timely manner that transformed OPAT into a fairer, more accessible solution with a procedural logic, and a 
process that was safer for both the patients and the healthcare professionals. However, we cannot but note 
that the solutions found, albeit efficacious, are limited to CFC’s internal field of action and to the actors of 
the practices in which the research group had a hands-on role. The real missing link is the efficacy of action 
at the proximal level outside the research group. OPAT with its problems and risks remains a procedure 
‘invisible’ to the hospital management system and, at the more distal level, to the local health services, 
which continue to shun responsibility for the patient’s home care needs.  
More surprisingly, though, the analysis has not revealed the existence of any link between the 
implementation of the new organizational practices and information systems (IS). This latter aspect is truly 
novel when we consider that: a) participative practices and ICT are usually seen as drivers of efficiency 
(Clark, Brudney, & Jang, 2013; Meijer, 2012); and b) the expectation that the recentness of the case analyzed 
would have translated into an intensive use of ICT artefacts (e.g., new software applications and new media) 
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to support the coordination and control activities of the co-production practices. The possible, partially 
correlated explanations can be summed up as follows: 
1) the issue is not on the agenda of the hospital’s healthcare management: the new management that 
took over in 2010 has not yet taken on board this dossier (in fact, the ethics committee has not yet 
been appointed). The new practice concerns small numbers in terms of CF patients and number of 
hospital beds;   
2) risk aversion, i.e., the new management is hesitant to institutionalize OPAT seeing it as high risk;  
3) professional reluctance of the healthcare professionals to cede status and control (Bovaird & 
Loeffler, 2012; Kirkpatrick, Bullinger, Lega, & Dent, 2013); 
4) lack of resources to allocate to new technological investments. 
As a result of these factors the ‘pilot phase’ remains ongoing, even though several years have passed since 
its launch date. 
The solution implemented to support OPAT is only partially effective and is inefficient from the 
organizational perspective, given that the current prevalent form of coordinating hospital and patients is the 
(heaviest) process of mutual adjustment. This dictates how CFC deals with emergency situations: for 
example, if beds are scarce, it transfers the patients to the Pulmonary ward.  
CONCLUSION 
The design and implementation of sustainable co-production practices poses new challenges for both the 
healthcare users and the healthcare providers. Co-production implies that the patient’s attitude (and that of 
their family and various caregivers) must be one of active participation in not only their therapy, but also the 
responsible organizational system. Co-production for the healthcare providers translates into further 
organizational complexity and additional coordination and control process costs.  
Merging two strands of thought on patient participation, i.e., public management studies and health 
psychology studies, the article attempts to take a snapshot (albeit partial) of just some of these challenges. 
That CFC has made an incomplete transition to co-production is attested by the empirical evidence, 
specifically: 
- the protocol and the different OPAT risk-management tools developed have not yet seen the light of 
day or been acknowledged outside the CFC;  
- there is only partial coherence between the OPAT processes and CFC’s internal organization 
processes; 
- no ICT solutions were implemented to help lighten the load of routine communications between the 
patient and CFC and between all the external non-hospital players, namely the GPs and the relevant 
local health authorities (Aziende sanitarie locali or ‘ASL). 
This state of affairs makes the unwilling clients of the CFC invisible to the hospital’s top management. 
One last but no less important point is that the reader should not infer that the combined use of public 
management studies and health psychological studies means that only these two disciplines have addressed 
the co-production issue; rather the choice was dictated by the need to keep the discussion manageable for 
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reasons of space. Therefore, to further enrich the analysis, future research will need to explore other 
disciplinary contributions. 
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